drugset
Drugs / EPIC MSC2011-001
last change Jul 2015 re-read 3 minutes ago

EPIC MSC2011-001

Cell therapy

Developed for
Crohn disease
Investigated by
Atlanta Clinical and Translational Science Institute · Emory University

Trials 1

today NCT01659762 · Ph 1
201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT01659762 Jul 2012 → Jul 2015 Crohn disease Emory University Completed No outcome recorded

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as EPIC MSC2011-001 “EPIC MSC2011-001” NCT01659762 ↗
Modality Cell therapy “autologous marrow-derived mesenchymal stromal cells ex vivo expanded numerically” NCT01659762 ↗
Route Intravenous “single intravenous infusion of EPIC MSC2011-001” NCT01659762 ↗